<PAPER>
  <mode2 name="ehp22_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="en">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title>Environ Health Perspect</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="doi">10.1289/ehp.11751</article-id>
        <article-id pub-id-type="publisher-id">ehp-117-910</article-id>
        <article-categories>
          <subj-group>
            <subject>Research</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Jenkins</surname>
              <given-names>Sarah</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-910">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Raghuraman</surname>
              <given-names>Nandini</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-910">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Eltoum</surname>
              <given-names>Isam</given-names>
            </name>
            <xref ref-type="aff" rid="af2-ehp-117-910">
              <sup>2</sup>
            </xref>
            <xref ref-type="aff" rid="af3-ehp-117-910">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Carpenter</surname>
              <given-names>Mark</given-names>
            </name>
            <xref ref-type="aff" rid="af4-ehp-117-910">
              <sup>4</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Russo</surname>
              <given-names>Jose</given-names>
            </name>
            <xref ref-type="aff" rid="af5-ehp-117-910">
              <sup>5</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Lamartiniere</surname>
              <given-names>Coral A.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-117-910">
              <sup>1</sup>
            </xref>
            <xref ref-type="aff" rid="af2-ehp-117-910">
              <sup>2</sup>
            </xref>
            <xref ref-type="corresp" rid="c1-ehp-117-910"/>
          </contrib>
        </contrib-group>
        <aff id="af1-ehp-117-910">
          <label>1</label>
          <addr-line>Department of Pharmacology and Toxicology</addr-line>
        </aff>
        <aff id="af2-ehp-117-910">
          <label>2</label>
          <addr-line>UAB Comprehensive Cancer Center and</addr-line>
        </aff>
        <aff id="af3-ehp-117-910">
          <label>3</label>
          <addr-line>Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA</addr-line>
        </aff>
        <aff id="af4-ehp-117-910">
          <label>4</label>
          <addr-line>Department of Mathematics and Statistics, Auburn University, Auburn, Alabama, USA</addr-line>
        </aff>
        <aff id="af5-ehp-117-910">
          <label>5</label>
          <addr-line>Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA</addr-line>
        </aff>
        <author-notes>
          <corresp id="c1-ehp-117-910">Address correspondence to C. Lamartiniere, Department of Pharmacology and Toxicology, University of Alabama at Birmingham, 1670 University Blvd., Volker Hall 124, Birmingham, AL 35294 USA. Telephone: (205) 934-7139. Fax: (205) 934-8240. E-mail: <email xlink:type="simple">Coral@uab.edu</email></corresp>
          <fn>
            <p>The authors declare they have no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <month>6</month>
          <year>2009</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>7</day>
          <month>1</month>
          <year>2009</year>
        </pub-date>
        <volume>117</volume>
        <issue>6</issue>
        <fpage>910</fpage>
        <lpage>915</lpage>
        <history>
          <date date-type="received">
            <day>2</day>
            <month>6</month>
            <year>2008</year>
          </date>
          <date date-type="accepted">
            <day>6</day>
            <month>1</month>
            <year>2009</year>
          </date>
        </history>
        <copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <abstract>
          <sec>
            <title>Background</title>
            <p>
              <s sid="2">Bisphenol A (BPA) is widely used in the manufacture of polycarbonate plastics, including infant formula bottles.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Objectives</title>
            <p>
              <s sid="3">Based on the reported endocrine disruptor activity of this polyphenol, we hypothesized that exposure to BPA early in life would elicit developmental changes in the mammary tissue and cause a predisposition for mammary cancer.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>
              <s sid="4">We exposed neonatal/prepubertal rats to BPA via lactation from nursing dams treated orally with 0, 25, and 250 &#956;g BPA/kg body weight/day.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
              <s sid="5">For tumorigenesis studies, female offspring were exposed to 30 mg dimethylbenzanthracene (DMBA)/kg body weight at 50 days of age.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Results</title>
            <p>
              <s sid="6">The combination of DMBA treatment with lactational exposure to BPA demonstrated a dose-dependent increase in mammary tumor multiplicity and reduced tumor latency compared with controls.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
              <s sid="7">In the absence of DMBA treatment, lactational BPA exposure resulted in increased cell proliferation and decreased apoptosis at 50 but not 21 days postpartum (shortly after last BPA treatment).<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
              <s sid="8">Using Western blot analysis, we determined that steroid receptor coactivators (SRCs) 1&#8211;3, Akt, phosphorylated Akt, progesterone receptor A (PR-A), and erbB3 proteins were significantly up-regulated at 50 days of age.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Conclusions</title>
            <p>
              <s sid="9">The data presented here provide the first evidence that maternal exposure to BPA during lactation increases mammary carcinogenesis in a DMBA-induced model of rodent mammary cancer.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
              <s sid="10">Changes in PR-A, SRC 1&#8211;3, erbB3, and Akt activity are consistent with increased cell proliferation and decreased apoptosis playing a role in mammary cancer susceptibility.<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
              <s sid="11">These alterations provide an explanation of enhanced mammary carcinogenesis after lactational BPA exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>apoptosis</kwd>
          <kwd>bisphenol A</kwd>
          <kwd>mammary cancer</kwd>
          <kwd>proliferation</kwd>
          <kwd>steroid receptor coactivators</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="12">Breast cancer etiology attributed to hereditary causes is low, accounting for an estimated 5&#8211;15% of all diagnosed cases (<xref ref-type="bibr" rid="b7-ehp-117-910">Colditz and Frazier 1995</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="13">Extrinsic factors, such as environment and lifestyle, may play substantial roles in the high incidence of breast cancer.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="14">Routine exposures to certain environmental contaminants, especially those with the ability to alter endocrine signaling, are currently being scrutinized for their potential roles in breast cancer causation.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="15">One such example can be found in the synthetic estrogen diethylstilbestrol (DES).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="16">Women were prescribed DES from 1947 until 1971 to prevent miscarriages.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="17">Not only was the drug therapeutically ineffective, but reports have established that women exposed <italic>in utero</italic> to DES showed an increased incidence of a rare type of vaginal cancer and an increased risk of developing breast cancer (<xref ref-type="bibr" rid="b14-ehp-117-910">Herbst et al. 1999</xref>; <xref ref-type="bibr" rid="b43-ehp-117-910">Troisi et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
        <s sid="18">These effects, occurring more than a decade after the original exposure, have caused greater public awareness of the role of early endocrine-disruptor exposure in lifetime breast cancer susceptibility.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="19">Likewise, recent media attention has focused on another common environmental endocrine disruptor, bisphenol A (BPA), as a potentially harmful chemical because of its widespread exposure to humans and reported endocrine-disruptor activity.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="20">BPA is ubiquitous in modern society.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="21">The main source of BPA stems from its widespread use to manufacture polycarbonate plastic and epoxy resins used in beverage and food containers, infant formula bottles, canned food liners, and some dental sealants, among other uses.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="22">However, the bonds that connect the BPA monomers are weak and highly subject to degradation even with normal use (<xref ref-type="bibr" rid="b24-ehp-117-910">Le et al. 2008</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="23">Factors such as time, higher temperatures, and pH extremes accelerate this process (<xref ref-type="bibr" rid="b17-ehp-117-910">Kang et al. 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="24"><xref ref-type="bibr" rid="b5-ehp-117-910">Calafat et al. (2005)</xref> found that 95% of adults surveyed (<italic>n</italic> = 394) had detectable concentrations of total (free plus conjugated) urinary BPA.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="25">In a pilot study of the concentrations of a panel of environmental chemicals in the urine of young girls, <xref ref-type="bibr" rid="b46-ehp-117-910">Wolff et al. (2007)</xref> reported similar findings.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
        <s sid="26">They reported total BPA concentrations ranging from below the limit of detection (0.3 &#956;g BPA/L) to 54.3 &#956;g BPA/L, with an average value of 2.0 &#956;g BPA/L (3.0 &#956;g BPA/g creatinine).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
        <s sid="27">A large-scale investigation supported these previous studies (<xref ref-type="bibr" rid="b6-ehp-117-910">Calafat et al. 2008</xref>), finding detectable concentrations of total BPA in 93% of &gt; 2,000 participants, averaging 2.6 &#956;g BPA/L.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="28">Furthermore, concentrations of total BPA increased with decreasing age.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="29">Children (6&#8211;11 years of age) had the highest concentrations of total BPA [least square geometric mean (LSGM), 4.5 &#956;g BPA/L], significantly higher than those of adults (LSGM, 2.5 &#956;g BPA/L) (<xref ref-type="bibr" rid="b6-ehp-117-910">Calafat et al. 2008</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        <s sid="30">BPA has been found to leach from polycarbonate infant formula bottles and as free and conjugated forms in breast milk, suggesting several sources for early BPA exposure and creating the concern that long-lasting adverse health effects may arise as a consequence (<xref ref-type="bibr" rid="b3-ehp-117-910">Brede et al. 2003</xref>; <xref ref-type="bibr" rid="b41-ehp-117-910">Sun et al. 2004</xref>; <xref ref-type="bibr" rid="b50-ehp-117-910">Ye et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="31">Several studies using animal models have linked early exposure to BPA with developmental and reproductive abnormalities in both sexes (<xref ref-type="bibr" rid="b15-ehp-117-910">Ho et al. 2006</xref>; <xref ref-type="bibr" rid="b16-ehp-117-910">Howdeshell et al. 1999</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="32">Perinatal exposure to BPA at 0.1 or 1.2 mg/kg body weight (bw) per day through drinking water significantly increased body weight, altered estrous cyclicity, and significantly lowered plasma concentrations of luteinizing hormone (<xref ref-type="bibr" rid="b35-ehp-117-910">Rubin et al. 2001</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
        <s sid="33">Perinatal exposure to BPA at 250 ng/kg bw/day through an osmotic pump caused significant alterations in the mammary gland, including an increased number of terminal end buds (TEBs), decreased apoptosis in TEBs, an increased percentage of cells expressing the progesterone receptor (PR), and increased lateral branching (<xref ref-type="bibr" rid="b31-ehp-117-910">Munoz-de-Toro et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
        <s sid="34">With gestational exposure alone, BPA advanced puberty and increased the number of terminal ducts, TEBs, alveolar buds, and preneoplastic lesions in the mammary gland (<xref ref-type="bibr" rid="b26-ehp-117-910">Markey et al. 2001</xref>; <xref ref-type="bibr" rid="b32-ehp-117-910">Murray et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
        <s sid="35">These and other studies provide a substantial amount of evidence to warrant further investigation into the potential deleterious effects caused by early exposure to BPA, especially in terms of mammary carcinogenesis.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="36">We sought to determine whether early exposure to BPA could accelerate mammary carcinogenesis in a dimethylbenzanthracene (DMBA) model of rodent mammary cancer.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
        <s sid="37">We treated lactating dams with low concentrations of BPA: 25 &#956;g/kg/day, which is one-half of the U.S. Environmental Protection Agency&#8217;s (EPA) daily oral reference dose of 50 &#956;g/kg/day (BPA 25 group), and 250 &#956;g/kg/day, which is 200-fold less than the lowest observed adverse effect level (LOAEL) of 50 mg/kg/day (BPA 250 group) (<xref ref-type="bibr" rid="b33-ehp-117-910">National Toxicology Program 1982</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
        <s sid="38">Thus, the present study provides the first evidence that oral administration of low concentrations of BPA to lactating dams can increase mammary cancer susceptibility of the female offspring in a DMBA-induced model.<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
        <s sid="39">Our data suggest that the mechanism of action behind this response is mediated through increased cell proliferation and decreased apoptosis and centers on an up-regulation of steroid receptor coactivator (SRC) proteins, erbB3, and Akt signaling in the mammary gland.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <sec>
          <title>Animals</title>
          <p>
            <s sid="40">Animal care and use were conducted according to established guidelines approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
            <s sid="41">Animals were treated humanely and with regard for alleviation of suffering.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
            <s sid="42">All animals were housed in a temperature- controlled facility with a 12 hr light/dark cycle.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
            <s sid="43">Female Sprague Dawley CD rats (Charles River, Raleigh, NC) were bred and observed for the presence of sperm.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
            <s sid="44">Sperm-positive females were separated, housed in polypropylene cages with glass water bottles (both polycarbonate/BPA free), and fed phytoestrogen-free AIN-93G pelleted diet (Harlan Teklad Global Diets, Wilmington, DE).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
            <s sid="45">On day 2 post-partum, all female offspring (5&#8211;8) and enough males to yield 10 offspring/litter were retained.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="46">Beginning on postpartum day 2 and continuing through postpartum day 20, the lactating dam of each litter was intragastrically gavaged with sesame oil vehicle (SO) or with BPA at 25 &#956;g/kg/day (BPA 25) or 250 &#956;g/kg/day (BPA 250) on Monday through Friday only (a total of 15 treatments).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
            <s sid="47">Because dam treatment for lactational exposure results in a single exposure group per treatment, we used only one offspring from each litter in each experiment.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Chemicals</title>
          <p>
            <s sid="48">We purchased BPA and sesame oil from Sigma Chemical Co. (St. Louis, MO).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
            <s sid="49">We purchased antibodies to erbB2, Bax, phosphorylated Bad, Bcl-2, caspase 2, caspase 3, and cleaved caspase 3 from Cell Signaling (Danvers, MA); antibodies to erbB3, estrogen receptor-&#945; (ER-&#945;), and PR-A and PR-B from Santa Cruz Biotechnology (Santa Cruz, CA); and antibodies to SRC-1, SRC-2/TIF2, and SRC-3/AIB1 from Becton, Dickenson and Company (Franklin Lakes, NJ).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Tumorigenesis study</title>
          <p>
            <s sid="50">At 50 days of age, one female offspring from each litter of each treatment group was given a single gavage of DMBA 30 mg/kg bw.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
            <s sid="51">This dose results in a low number of mammary tumors and allows chemicals that predispose for mammary cancer to increase the number of mammary adenocarcinomas (<xref ref-type="bibr" rid="b4-ehp-117-910">Brown et al. 1998</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
            <s sid="52">Because dam treatment for lactational exposure results in a single exposure group per treatment, we used only one offspring from each litter in each experiment.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
            <s sid="53">There were 32, 34, and 24 female offspring in the SO, BPA 25, and BPA 250 groups, respectively, all derived from individual litters.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
            <s sid="54">We palpated animals twice weekly to monitor tumor development and recorded data on palpable tumor latency, location, tumor burden, and multiplicity.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
            <s sid="55">Animals underwent necropsy at 12 months of age or when tumor burden exceeded 10% of body weight.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
            <s sid="56">All tumors and gross lesions were dissected out, fixed in formalin, and embedded in paraffin, and sections were prepared for pathologic evaluation.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/></s>
            <s sid="57">Coded slides were classified as to tumor type, tissue of origin, and degree of invasiveness by a board-certified pathologist (I.E.).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/></s>
            <s sid="58">Histopathologic characterization of mammary neoplastic lesions included carcinoma grade, proliferation index, and malignancy evaluations, as described by <xref ref-type="bibr" rid="b30-ehp-117-910">Meyer et al. (2005)</xref>.<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Mammary dissections</title>
          <p>
            <s sid="59">When animals were 21 and 50 days of age, we processed two sets of identically treated rats using ketamine/xylazine anesthesia for live collection of mammary glands.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/></s>
            <s sid="60">The fourth abdominal mammary glands were collected from each rat; one set of the mammary glands was snap frozen in liquid nitrogen for immunoblotting (<italic>n</italic> = 8 per treatment group), and the contralateral glands were fixed in formalin and embedded in paraffin (<italic>n</italic> = 5 per treatment group).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/></s>
            <s sid="61">At 50 days of age, all females were killed during the estrous phase.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="display-objects">
          <title>Figures</title>
          <fig id="f1-ehp-117-910" position="float">
            <label>Figure 1</label>
            <caption>
              <p>DMBA induced mammary tumors (mean &#177; SE) in rats exposed lactationally to BPA. <italic>p</italic>-Values reflect comparison with control.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11751.g001" xlink:type="simple"/>
          </fig>
          <fig id="f2-ehp-117-910" position="float">
            <label>Figure 2</label>
            <caption>
              <p>Cell proliferation and apoptosis in mammary glands of 50-day-old BPA 250 rats. (<italic>A</italic>) Ki-67 expression as an indicator of cell proliferation (left) and the TUNEL assay as measure of apoptosis (right). TEBs from five biologically distinct samples (<italic>n</italic> = 5) were analyzed per treatment. Magnification, 40&#215;; bar = 100 &#956;m. (<italic>B</italic>) Index values (mean &#177; SE) as a percentage of the control group. (<italic>C</italic>) Results [no. (%)] of cell proliferation and apoptosis analyses.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11751.g002" xlink:type="simple"/>
          </fig>
          <fig id="f3-ehp-117-910" position="float">
            <label>Figure 3</label>
            <caption>
              <p>Akt and pAkt protein expression in mammary glands of 50-day-old SO controls and BPA 250 rats detected by Western blot analysis [see also Supplemental Material, Figure 1 (<ext-link ext-link-type="uri" xlink:href="http://www.ehponline.org/members/2009/11751/suppl.pdf" xlink:type="simple">http://www.ehponline.org/members/2009/11751/suppl.pdf</ext-link>)]. For each treatment group, <italic>n</italic> = 8. Values shown are mean density &#177; SE as a percentage of control group.</p>
              <p>*<italic>p</italic>= 0.05, and **<italic>p</italic>= 0.001, compared with control.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11751.g003" xlink:type="simple"/>
          </fig>
          <fig id="f4-ehp-117-910" position="float">
            <label>Figure 4</label>
            <caption>
              <p>ER-&#945;, PR-A, PR-B, SRC-1, SRC-2, SRC-3, erbB2, and erbB3 protein expression in mammary glands of 50-day-old SO control and BPA 250 rats detected by Western blot analysis [see also Supplemental Material, Figure 1 (<ext-link ext-link-type="uri" xlink:href="http://www.ehponline.org/members/2009/11751/suppl.pdf" xlink:type="simple">http://www.ehponline.org/members/2009/11751/suppl.pdf</ext-link>)]. For each treatment group, <italic>n</italic> = 8. Values shown are mean density &#177; SE as a percentage of the control group.</p>
            </caption>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11751.g004" xlink:type="simple"/>
          </fig>
        </sec>
        <sec>
          <title>Hormone concentration</title>
          <p>
            <s sid="62">At 50 days of age, female offspring lactationally exposed via dams treated with BPA 250 or an equal volume of sesame oil were decapitated and trunk blood was collected.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/></s>
            <s sid="63">We measured serum 17&#946;-estradiol and progesterone concentrations using radioimmunoassays (Diagnostic Systems Laboratories, Webster, TX) as described by the manufacturer.<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
            <s sid="64">All samples were run in duplicate, with eight samples per group, by J. Mahan (Obstetrics and Gynecology Department, University of Alabama at Birmingham).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Immunohistochemical staining</title>
          <p>
            <s sid="65">To determine cell proliferation, tissue blocks were sectioned at 5 &#956;m and placed on glass slides.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/></s>
            <s sid="66">The slides were deparaffinized and rehydrated through xylene and graded alcohol washes.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/></s>
            <s sid="67">Slides were boiled in citrate buffer for 15 min, incubated in hydrogen peroxide to quench endogenous peroxidases, and blocked using the appropriate serum.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/></s>
            <s sid="68">We incubated the slides in Ki-67 primary antibody (Dako, Glostrup, Denmark) overnight in a humidified chamber.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp26" novelty="None" advantage="None"/></s>
            <s sid="69">After incubating the tissue sections in the appropriate conjugated secondary antibody, we employed the use of the ImmPRESS kit (Vector Laboratories, Burlingame, CA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp27" novelty="None" advantage="None"/></s>
            <s sid="70">Positively stained cells were visualized by incubating the tissue sections with 3,3&#8242;-diamonobenzidine and counterstained with hematoxylin.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp28" novelty="None" advantage="None"/></s>
            <s sid="71">Tissue sections were dehydrated with graded alcohols, cleared with xylene, and mounted with a glass coverslip.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp29" novelty="None" advantage="None"/></s>
            <s sid="72">We used five biologically distinct samples derived from individual litters, and counted a minimum of three TEB structures per slide.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp30" novelty="None" advantage="None"/></s>
            <s sid="73">We assessed cell proliferation by noting intense nuclear staining for Ki-67 protein.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp31" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Apoptosis assay</title>
          <p>
            <s sid="74">We determined the rate of apoptosis using the ApopTag Plus Peroxidase <italic>In Situ</italic> Apoptosis Detection kit (Chemicon International, Billerica, MA) according to the manufacturer&#8217;s protocol.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp32" novelty="None" advantage="None"/></s>
            <s sid="75">This method detects the apoptotic cells by the indirect TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) method.<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
            <s sid="76">Cells that stained positively and exhibited morphologic characteristics of apoptosis were counted as positive.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
            <s sid="77">We used five biologically distinct samples per treatment and counted a minimum of three TEB structures per slide.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp33" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Immunoblotting</title>
          <p>
            <s sid="78">We diced whole mammary glands and homogenized them in RIPA lysis buffer (Pierce Biotechnolgy, Rockford, IL) using a pestle and sample-grinding kit (GE Healthcare Inc., Piscataway, NJ).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp34" novelty="None" advantage="None"/></s>
            <s sid="79">After homogenization, the samples were centrifuged for 20 min at 16,000 &#215; <italic>g</italic> at 4&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp35" novelty="None" advantage="None"/></s>
            <s sid="80">We quantified protein lysate recovered from the residual tissue using the Bradford assay (Bio-Rad Laboratories, Hercules, CA).<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
            <s sid="81">Equal protein content (40 &#956;g) was loaded onto precast sodium dodecyl sulfate (SDS) Tris-HCl 4&#8211;20% polyacrylamide gels (Bio-Rad).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp36" novelty="None" advantage="None"/></s>
            <s sid="82">Proteins were wet transferred to a nitrocellulose membrane overnight.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp37" novelty="None" advantage="None"/></s>
            <s sid="83">The membrane was blocked at room temperature, and the primary antibody was added and incubated overnight at 4&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp38" novelty="None" advantage="None"/></s>
            <s sid="84">Secondary antibody and chemilume (Pierce Biotechnology, Rockford, IL) were added and protein expression was visualized using film exposures.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp39" novelty="None" advantage="None"/></s>
            <s sid="85">We assessed densitometry patterns using Quantity One computer software (Bio-Rad).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp40" novelty="None" advantage="None"/></s>
            <s sid="86">We used positive protein controls purchased from the supplier for the corresponding antibodies and Kaleidoscope Precision Plus protein and prestained SDS-PAGE Broad Range standards (Bio-Rad) to identify the protein of interest.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp41" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Statistical methods</title>
          <p>
            <s sid="87">We analyzed the time-to-event data [e.g., time-to-first-tumor (latency) and time-to-sacrifice (tumor burden)] using the LIFETEST and LIFEREG procedures in SAS (SAS Institute Inc., Cary, NC).<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
            <s sid="88">We first estimated survival functions for each group using the Kaplan-Meier method; we then compared these across the three groups using the Wilcoxon log-rank test, and parametrically using survival regression analysis (<xref ref-type="bibr" rid="b8-ehp-117-910">Collette 2003</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
            <s sid="89">Those animals that had not developed a tumor by the end of the study or that were sacrificed were censored, with either the sacrifice time or the end of study treated as censoring times.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp42" novelty="None" advantage="None"/></s>
            <s sid="90">We analyzed tumor multiplicity data with the GENMOD (generalized linear models) procedure in SAS using generalized Poisson regression on the tumor appearance rates (assuming a negative binomial distribution) (<xref ref-type="bibr" rid="b28-ehp-117-910">McCullagh and Nelder 1989</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="None" advantage="None"/></s>
            <s sid="91">Because there was a positive correlation between number of tumors and number of days in the study, we performed the tests on multiplicity after adjusting for the number of days each animal was in the study.<CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="None" advantage="None"/></s>
            <s sid="92">Values for multiplicity are expressed as mean &#177; SE.<CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="None" advantage="None"/></s>
            <s sid="93">For cell proliferation and apoptosis, the resulting values (stained vs. unstained cells) were used to construct a contingency table.<CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="None" advantage="None"/></s>
            <s sid="94">We tested Western blots for equal variance using a two-sample <italic>F</italic>-test, and we used the appropriate (assuming equal or unequal variance) two-sample <italic>t</italic>-test.<CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="None" advantage="None"/></s>
            <s sid="95">We considered <italic>p</italic>-values &#8804; 0.05 to be statistically significant.<CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p>
          <s sid="96">Female rats in the BPA 25 and BPA 250 groups had similar body weights compared with the SO group at 2, 7, 14, 21, 35, 50, and 100 days of age.<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
          <s sid="97">Puberty, as measured by the age at vaginal opening, was not significantly altered, occurring on days 31.39 &#177; 0.24, 31.15 &#177; 0.21, and 31.88 &#177; 0.14 for SO, BPA 25, and BPA 250 groups, respectively.<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
          <s sid="98">At 50 days of age, serum 17&#946;-estradiol concentration was 34.4 &#177; 2.7 and 23.6 &#177; 4.7 pg/mL for the SO and BPA 250 groups, respectively.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
          <s sid="99">Circulating progesterone concentrations were 12.5 &#177; 2.8 and 9.9 &#177; 1.9 ng/mL in 50-day-old rats in the SO and BPA 250 groups, respectively.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
          <s sid="100">Neither of these findings was significantly different.<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
          <s sid="101">We investigated estrous cyclicity in adult female offspring from all three treatment groups for 19 consecutive days, starting at 7&#8211;8 weeks of age, and found no significant difference.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
        </p>
        <sec>
          <title>DMBA-induced mammary carcinogenesis</title>
          <p>
            <s sid="102">Female rats in the SO, BPA 25, and BPA 250 groups gavaged at day 50 with DMBA exhibited a BPA dose-dependent increase in mammary tumors: 2.84 &#177; 0.31, 3.82 &#177; 0.43, and 5.00 &#177; 0.88 mammary tumors per rat, respectively (<xref ref-type="fig" rid="f1-ehp-117-910">Figure 1</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
            <s sid="103">After adjusting for the length of time on the study (time before sacrifice), we found that the BPA 250 group had a significantly greater number of tumors per rat than did the control group (<italic>p</italic> = 0.004).<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
            <s sid="104">Treatment with BPA also significantly reduced tumor latency, with median tumor latencies of 65, 53 (<italic>p</italic> = 0.058), and 56.5 (<italic>p</italic> = 0.025) days for 0, BPA 25, and BPA 250, respectively.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
            <s sid="105">Although the BPA 25 group had a similar decrease in latency and an increase in tumor multiplicity (<italic>p</italic> = 0.131), neither of these changes reached statistical significance.<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
            <s sid="106">Histopathologic evaluation of these tumors revealed no changes in the carcinoma score, tumor burden, or length of time in the study for any treatment group (data not shown).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Apoptosis and cell proliferation</title>
          <p>
            <s sid="107">Previous reports have shown that exposure to BPA during the perinatal period through subcutaneously implanted pumps can lead to long-lasting effects on cell turnover (<xref ref-type="bibr" rid="b10-ehp-117-910">Durando et al. 2007</xref>; <xref ref-type="bibr" rid="b31-ehp-117-910">Munoz-de-Toro et al. 2005</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
            <s sid="108">Therefore, we assessed the rate of cellular proliferation and apoptosis in the structure most susceptible to mammary carcinogenesis, the TEB.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
            <s sid="109">Interestingly, cell proliferation in TEBs of 50-day-old but not 21-day-old rats was significantly increased in those animals lactationally exposed to BPA 250 (<italic>p</italic> &lt; 0.001; <xref ref-type="fig" rid="f2-ehp-117-910">Figure 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
            <s sid="110">Equally important, apoptosis was significantly decreased in the mammary gland of 50-day-old but not 21-day-old BPA 250 rats (<italic>p</italic>= 0.001).<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Akt and phosphorylated Akt (pAkt)</title>
          <p>
            <s sid="111">Because of the statistically significant decrease in apoptosis in adult BPA 250 rats, we measured the expression of several proteins commonly linked to apoptosis.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
            <s sid="112">At 50 days of age, Akt (<italic>p</italic> = 0.001) and pAkt (<italic>p</italic> = 0.050) were significantly different between exposure groups, with each protein showing nearly a 2-fold increase over control expression levels [<xref ref-type="fig" rid="f3-ehp-117-910">Figure 3</xref>; see also Supplemental Material, Figure 1 (available online at <ext-link ext-link-type="uri" xlink:href="http://www.ehponline.org/members/2009/11751/suppl.pdf" xlink:type="simple">http://www.ehponline.org/members/2009/11751/suppl.pdf</ext-link>)].<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
            <s sid="113">Expressions of Bad, phosphorylated Bad, Bcl-2, caspase 2, caspase 3, and caspase 9 were not significantly different.<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
            <s sid="114">Furthermore, none of these proteins was differentially regulated at 21 days of age, suggesting that protein expression and activity of Akt were latent effects from BPA exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Sex steroid receptors, SRCs, and growth factor receptors</title>
          <p>
            <s sid="115">Given the statistically significant increase in cell proliferation in mammary TEBs of 50-day-old offspring exposed lactationally to BPA, we assessed proteins implicated in cellular proliferation.<CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Exp" conceptID="Exp43" novelty="None" advantage="None"/></s>
            <s sid="116">Primarily because of BPA&#8217;s reported weakly estrogenic effects, we initially focused on sex steroid receptors.<CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="None" advantage="None"/></s>
            <s sid="117">We found that BPA-exposed females exhibited an up-regulation of PR-A of 54% compared with control [<italic>p</italic> = 0.02; <xref ref-type="fig" rid="f4-ehp-117-910">Figure 4</xref>; see Supplemental Material, Figure 1 (<ext-link ext-link-type="uri" xlink:href="http://www.ehponline.org/members/2009/11751/suppl.pdf" xlink:type="simple">http://www.ehponline.org/members/2009/11751/suppl.pdf</ext-link>)].<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
            <s sid="118">Because <italic>PR-A</italic> is a known downstream target of estrogen signaling, we also assessed the expression of coregulator proteins known to play a role in increased estrogen signaling and breast cancer.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met18" novelty="None" advantage="None"/></s>
            <s sid="119">We found all three members of the p160 family of SRC proteins, SRC-1 (<italic>p</italic> = 0.001), SRC-2 (<italic>p</italic> = 0.003), and SRC-3 (<italic>p</italic> &lt; 0.001), to be significantly up-regulated in response to lactational exposure to BPA [<xref ref-type="fig" rid="f4-ehp-117-910">Figure 4</xref>; see also Supplemental Material, Figure 1 (<ext-link ext-link-type="uri" xlink:href="http://www.ehponline.org/members/2009/11751/suppl.pdf" xlink:type="simple">http://www.ehponline.org/members/2009/11751/suppl.pdf</ext-link>)].<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
            <s sid="120">Finally, a correlation has been documented between SRC expression and expression of the erbB family of tyrosine kinases.<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
            <s sid="121">Although we noted no significant differences for erbB1 (epidermal growth factor receptor) or erbB2 (neu), we found a significant increase in erbB3 expression (<italic>p</italic>= 0.01).<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="122">We report for the first time that oral exposure of rats to BPA via lactating dams significantly reduced tumor latency and increased tumor multiplicity in offspring in a dose-dependent manner in a DMBA model of rodent mammary carcinogenesis.<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
          <s sid="123">In the design of these studies to determine if BPA would predispose for mammary cancer, our first considerations were model, route and timing of exposure, and dose.<CoreSc1 atype="GSC" type="Met" conceptID="Met19" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="124">Although no model is perfect, we chose rats because of the reasonable similarity in mammary gland development and use of the chemically induced mammary cancer model for tumorigenesis studies (<xref ref-type="bibr" rid="b36-ehp-117-910">Russo IH and Russo 1978</xref>; <xref ref-type="bibr" rid="b37-ehp-117-910">Russo et al. 1990</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met20" novelty="None" advantage="None"/></s>
          <s sid="125">Because humans are exposed to BPA primarily by ingestion, we treated rats orally as opposed to injections or subcutaneous implants.<CoreSc1 atype="GSC" type="Met" conceptID="Met21" novelty="None" advantage="None"/></s>
          <s sid="126">This takes into consideration metabolism and disposition.<CoreSc1 atype="GSC" type="Met" conceptID="Met22" novelty="None" advantage="None"/></s>
          <s sid="127">Because timing of exposure is important to target organ toxicity and mechanism of action, we selected the neonatal/prepubertal period for these studies.<CoreSc1 atype="GSC" type="Met" conceptID="Met23" novelty="None" advantage="None"/></s>
          <s sid="128">In choosing the doses, we took into consideration <italic>a</italic>) the reports of estimated exposures of preschool children BPA at 52&#8211;74 ng/kg bw/day (<xref ref-type="bibr" rid="b45-ehp-117-910">Wilson et al. 2007</xref>); <italic>b</italic>) that the European Commission estimated BPA exposure in infants (3&#8211;6 months of age) at 0.2&#8211;8.3 &#956;g/kg bw/day (<xref ref-type="bibr" rid="b12-ehp-117-910">European Food Safety Authority 2006</xref>); and <italic>c</italic>) that the European Union estimated exposure in infants (1&#8211;6 months of age) at 7&#8211;8 &#956;g/kg bw/day (<xref ref-type="bibr" rid="b11-ehp-117-910">European Commission 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
          <s sid="129">Accordingly, we chose to treat the dams with a low dose of BPA (25 &#956;g/kg bw/day, 50% of the U.S. EPA&#8217;s daily oral reference dose of 50 &#956;g/kg bw/day) and a dose that was 10-fold higher than the low dose (250 &#956;g/kg/day).<CoreSc1 atype="GSC" type="Met" conceptID="Met24" novelty="None" advantage="None"/></s>
          <s sid="130">Furthermore, we exposed the offspring to significantly less BPA than the dose administered to the dams because of dilution factors resulting from maternal and fetal metabolism and disposition, lactation, and number of offspring.<CoreSc1 atype="GSC" type="Met" conceptID="Met25" novelty="None" advantage="None"/></s>
          <s sid="131">Although the actual blood and tissue concentrations have yet to be determined in our animals, we surmise that the effects reported in the present study are a result of low exposures to BPA.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
          <s sid="132">Likewise, it is possible that the effects of BPA could be on the dam, which could alter hormones and composition of the milk and consequently the offspring, issues that we have not investigated.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="133">Our mammary cancer findings are supported by other <italic>in vivo</italic> studies.<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
          <s sid="134"><xref ref-type="bibr" rid="b10-ehp-117-910">Durando et al. (2007)</xref> showed that prenatal exposure to BPA (via an osmotic pump, which equates to subcutaneous administration) coupled to a subcarcinogenic dose of <italic>N</italic>-nitroso-<italic>N</italic>-methylurea resulted in an increased percentage of preneoplastic and neoplastic lesions in the mammary gland.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
          <s sid="135">Similarly, <xref ref-type="bibr" rid="b32-ehp-117-910">Murray et al. (2007)</xref> found that exposure to BPA during the prenatal period through an osmotic pump resulted in the development of carcinoma <italic>in situ</italic> in the mammary gland even in the absence of an additional carcinogen.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
          <s sid="136">Although these studies used different periods of exposure, route of administration, and end point, they still provide support for our findings and add to the growing literature that implicates a detrimental role for early BPA exposure in mammary cancer susceptibility.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="137">Our cell proliferation and apoptosis studies showed that no significant effects stemmed from direct BPA exposure (at 21 days of age).<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
          <s sid="138">However, delayed effects did occur.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
          <s sid="139">At 50 days of age, &gt; 4 weeks after discontinuing treatment with BPA, cell proliferation was significantly increased, and apoptosis was significantly decreased, in the mammary glands of rats lactationally exposed to BPA.<CoreSc1 atype="GSC" type="Res" conceptID="Res26" novelty="None" advantage="None"/></s>
          <s sid="140">Females lactationally exposed to BPA had a proliferation to apoptosis ratio twice that of control rats in the structures most susceptible to carcinogenesis in the mammary gland, the TEBs (<xref ref-type="bibr" rid="b36-ehp-117-910">Russo J and Russo 1978</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res27" novelty="None" advantage="None"/></s>
          <s sid="141">Subsequent Western blotting analysis revealed that a key regulator of apoptosis, Akt and the biologically active pAkt, was significantly up-regulated.<CoreSc1 atype="GSC" type="Res" conceptID="Res28" novelty="None" advantage="None"/></s>
          <s sid="142">These findings were not unexpected given that both prenatal and perinatal exposures to BPA in rodents (via osmotic pumps) have been reported to cause decreased apoptosis in the mammary gland (<xref ref-type="bibr" rid="b10-ehp-117-910">Durando et al. 2007</xref>; <xref ref-type="bibr" rid="b31-ehp-117-910">Munoz-de-Toro et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
          <s sid="143">With the balance of cell turnover disrupted so severely, such a situation could provide an environment more susceptible to exposure to a secondary carcinogen, such as DMBA.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
          <s sid="144">The significant increase in proliferation observed in our study, but not in other studies, may be a function of differing BPA exposure schemes or routes of administration (i.e., postnatal vs. prenatal exposures, oral administration vs. subcutaneous implants, dose, etc.) that can affect metabolism and disposition.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="145">By most accounts, BPA&#8217;s mechanism of action is thought to revolve around its weak estrogenic activity.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
          <s sid="146">Hence, we evaluated the effects of lactational exposure to BPA on sex steroid receptors in the mammary gland using Western blot analysis.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="None" advantage="None"/></s>
          <s sid="147">Although we observed no significant change for ER-&#945; or PR-B, we observed a significant increase for PR-A.<CoreSc1 atype="GSC" type="Res" conceptID="Res29" novelty="None" advantage="None"/></s>
          <s sid="148">This finding is supported by the work of <xref ref-type="bibr" rid="b31-ehp-117-910">Munoz-de-Toro et al. (2005)</xref>, who found an increased percentage of cells expressing PR in the mammary gland after perinatal BPA treatment.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="149">PR has been highly implicated in breast cancer by functioning as the nuclear receptor for the sex hormone progesterone.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="150">Recent work has indicated that the two isoforms of PR function in distinct manners and are induced by differing stimuli.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
          <s sid="151">PR-A is the predominant isoform expressed in the pubertal, virgin mammary gland and is vital to side branching (<xref ref-type="bibr" rid="b1-ehp-117-910">Aupperlee et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          <s sid="152">Studies of transgenic mice engineered to overexpress PR-A have demonstrated abnormalities in the mammary gland, including the development of hyperplastic lesions with a disorganized basement membrane and reduced cell-to-cell adhesion (<xref ref-type="bibr" rid="b40-ehp-117-910">Shyamala et al. 1998</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
          <s sid="153">Interestingly, PR-A has also been reported to be induced by estradiol in Sprague Dawley rats (<xref ref-type="bibr" rid="b20-ehp-117-910">Kariagina et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac36" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="154">To ensure that increased expression of PR-A was not a result of lactational BPA causing increased concentrations of circulating estradiol, we measured hormone concentrations in rats at 50 days of age.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/></s>
          <s sid="155">We found no significant difference between the BPA-exposed and control groups, confirming that sex hormone concentrations were not altered by lactational BPA exposure.<CoreSc1 atype="GSC" type="Res" conceptID="Res30" novelty="None" advantage="None"/></s>
          <s sid="156">However, no significant changes that we observed manifested before the onset of puberty.<CoreSc1 atype="GSC" type="Res" conceptID="Res31" novelty="None" advantage="None"/></s>
          <s sid="157">One potential explanation is that early exposure to BPA increased the sensitivity of the mammary gland to the hormones of puberty.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/></s>
          <s sid="158">We found increased cell proliferation and PR-A expression coupled with decreased apoptosis long after the original exposure to BPA ceased.<CoreSc1 atype="GSC" type="Res" conceptID="Res32" novelty="None" advantage="None"/></s>
          <s sid="159">It is possible that early BPA exposure imprints or sensitizes the rat to the effects of postpubertal hormone.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp4" novelty="None" advantage="None"/></s>
          <s sid="160">Then, as the concentrations of circulating sex hormones increase postpubertally, the indirect effects of BPA manifest.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp5" novelty="None" advantage="None"/></s>
          <s sid="161">This theory has recently been suggested by <xref ref-type="bibr" rid="b44-ehp-117-910">Wadia et al. (2007)</xref>, who showed that ovariectomized CD-1 mice prenatally exposed to BPA displayed a significantly heightened response in the mammary gland after an estrogenic stimulus.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac37" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="162">A potential mechanism involved in a heightened response to estrogen is through SRC proteins.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp6" novelty="None" advantage="None"/></s>
          <s sid="163">SRCs function to accelerate hormone-bound nuclear-receptor&#8211;induced transcription through weak histone acetyltransferase activity and by recruiting chromatin modification enzymes to the promoter/enhancer regions of target genes.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac38" novelty="None" advantage="None"/></s>
          <s sid="164">The endogenous milieu of coregulator proteins in the target tissue are thought to have great impact on the activation of nuclear receptors, such as ER and PR, and be the basis of chemotherapeutic resistance and tissue-specific function of selective ER modulators (<xref ref-type="bibr" rid="b39-ehp-117-910">Schiff et al. 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac39" novelty="None" advantage="None"/></s>
          <s sid="165">We found the expression of the p160 family of SRC proteins (SRC-1, SRC-2, and SRC-3) to be dramatically increased at 50 days of age after lactational exposure to BPA.<CoreSc1 atype="GSC" type="Res" conceptID="Res33" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="166">Descriptions of SRC activity, as reported through transgenic mouse models, provide a close correlation with many of the reported effects of early exposure to BPA.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac40" novelty="None" advantage="None"/></s>
          <s sid="167">Alterations in morphology, such as decreased side branching, decreased ductal elongation, and increased alveologenesis, have been reported in mice deficient in SRC-1 and SRC-3 (<xref ref-type="bibr" rid="b48-ehp-117-910">Xu et al. 1998</xref><xref ref-type="bibr" rid="b47-ehp-117-910">, 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac41" novelty="None" advantage="None"/></s>
          <s sid="168">It seems plausible that increased expression of the SRCs in the mammary glands, as reported in our study, would confer a greater incidence of side branching and alveologenesis.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
          <s sid="169">Indeed, mice overexpressing SRC-3/AIB1 showed a greater degree of ductal branching (<xref ref-type="bibr" rid="b42-ehp-117-910">Torres-Arzayus et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac42" novelty="None" advantage="None"/></s>
          <s sid="170">Three independent reports on early BPA exposure have described similar morphologic abnormalities, such as increased side branching and alveologenesis, in the mammary gland (<xref ref-type="bibr" rid="b26-ehp-117-910">Markey et al. 2001</xref><xref ref-type="bibr" rid="b27-ehp-117-910">, 2005</xref>; <xref ref-type="bibr" rid="b31-ehp-117-910">Munoz-de-Toro et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac43" novelty="None" advantage="None"/></s>
          <s sid="171">Knocking out SRC-3/AIB1 in mice has been shown to confer resistance to DMBA-induced mammary cancer, resulting in an increased tumor latency, reduced multiplicity, and slower growth rate (<xref ref-type="bibr" rid="b22-ehp-117-910">Kuang et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac44" novelty="None" advantage="None"/></s>
          <s sid="172">Our results demonstrate that lactational BPA exposure results in a significant increase in DMBA-induced mammary cancer susceptibility at a time when the local environment of the mammary gland has drastically up-regulated expression of all of the SRCs.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
          <s sid="173">Likewise, transgenic mice engineered to overexpress SRC-3 exhibit an increased susceptibility to mammary cancer, developing mammary hypertrophy, hyperplasia, and malignant tumor formation after a long latency period (<xref ref-type="bibr" rid="b42-ehp-117-910">Torres-Arzayus et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac45" novelty="None" advantage="None"/></s>
          <s sid="174">Prenatal BPA has been shown to cause an increase in premalignant and/or malignant lesions in the mammary glands of rats during adulthood when given alone or in concert with a sub-carcinogenic dose of <italic>N</italic>-nitroso-<italic>N</italic>-methylurea (<xref ref-type="bibr" rid="b10-ehp-117-910">Durando et al. 2007</xref>; <xref ref-type="bibr" rid="b32-ehp-117-910">Murray et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac46" novelty="None" advantage="None"/></s>
          <s sid="175">SRC-3/AIB1-deficient mice also show reduced Akt activity, whereas SRC-3/AIB1&#8211;over-expressing mice show increased Akt activation and reduction in apoptosis in the mammary gland and in mammary tumors (<xref ref-type="bibr" rid="b22-ehp-117-910">Kuang et al. 2005</xref>; <xref ref-type="bibr" rid="b42-ehp-117-910">Torres-Arzayus et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac47" novelty="None" advantage="None"/></s>
          <s sid="176">We report here that lactational BPA is able to up-regulate Akt expression/activation and down-regulate apoptosis in the mammary gland during adulthood.<CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
          <s sid="177">Finally, <xref ref-type="bibr" rid="b49-ehp-117-910">Xu et al. (2007)</xref> described perinatal exposure to BPA in Sprague Dawley rats causing a significant increase in <italic>SRC-1</italic> mRNA and protein in the hippocampus of male pups.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac48" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="178">A relationship has been established in the literature between the SRCs, HER2/erbB2, and the Akt signaling pathway.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac49" novelty="None" advantage="None"/></s>
          <s sid="179">One study reported SRC-1 to be overexpressed in 46% of HER2-positive breast tumors but in only 6% of HER2-negative breast tumors (<xref ref-type="bibr" rid="b13-ehp-117-910">Fleming et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac50" novelty="None" advantage="None"/></s>
          <s sid="180"><xref ref-type="bibr" rid="b2-ehp-117-910">Bouras et al. (2001)</xref> reported a positive correlation between the expression of SRC-3, HER2, and p53.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac51" novelty="None" advantage="None"/></s>
          <s sid="181">Although HER2 breast tumors are frequently cited as resulting in shorter disease-free survival, coupling HER2 overexpression with SRC-3 overexpression has been reported to worsen the prognosis further, adding a greater risk of refractory disease (<xref ref-type="bibr" rid="b21-ehp-117-910">Kirkegaard et al. 2007</xref>; <xref ref-type="bibr" rid="b29-ehp-117-910">Mc Ilroy et al. 2006</xref>; <xref ref-type="bibr" rid="b34-ehp-117-910">Osborne et al. 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac52" novelty="None" advantage="None"/></s>
          <s sid="182">SRC-3/AIB1 has also been shown to control the activity of both erbB1 and HER2 (erbB2) (<xref ref-type="bibr" rid="b23-ehp-117-910">Lahusen et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac53" novelty="None" advantage="None"/></s>
          <s sid="183">Down-regulating erbB3 through small interfering RNA reduces Akt activity (<xref ref-type="bibr" rid="b25-ehp-117-910">Liu et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac54" novelty="None" advantage="None"/></s>
          <s sid="184">These results suggest that coactivator proteins may serve as essential mediator proteins, linking crosstalk between growth factors and sex steroid signaling pathways.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac55" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="185">Although we noted no changes between treatment groups in the expression of erbB1, erbB2, or erbB4, we found a significant up-regulation for erbB3.<CoreSc1 atype="GSC" type="Res" conceptID="Res34" novelty="None" advantage="None"/></s>
          <s sid="186">erbB3, despite lacking a catalytic domain, has been reported to be the preferred dimerization partner for erbB2.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac56" novelty="None" advantage="None"/></s>
          <s sid="187">This pairing has also been reported to induce the most mitogenic response that preferentially signals through the Akt pathway (<xref ref-type="bibr" rid="b19-ehp-117-910">Karamouzis et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac57" novelty="None" advantage="None"/></s>
          <s sid="188">Although overexpression of erbB3 alone may induce mammary carcinogenesis, overexpression of both erbB2 and erbB3 has been observed frequently in a transgenic mouse model that overexpresses the wild-type erbB2 protein, and in human breast tumor samples (<xref ref-type="bibr" rid="b19-ehp-117-910">Karamouzis et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac58" novelty="None" advantage="None"/></s>
          <s sid="189">This dual over-expression has been linked to more aggressive disease and increased development of drug-resistant cancer.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac59" novelty="None" advantage="None"/></s>
          <s sid="190">Thus, although we did not observe the up-regulation of erbB2 at this specific time point (50 days of age), an up-regulation of erbB3 could provide ample access to a binding partner for erbB2 and provide a local environment more prone for cancer development.<CoreSc1 atype="GSC" type="Res" conceptID="Res35" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>
          <s sid="191">The data we present here provide the first evidence that maternal exposure to BPA during lactation decreased time to first tumor latency and increased the number of DMBA-induced mammary tumors in female offspring.<CoreSc1 atype="GSC" type="Con" conceptID="Con10" novelty="None" advantage="None"/></s>
          <s sid="192">We conclude that increased cell proliferation and decreased apoptosis at the time of DMBA administration play a vital role in BPA&#8217;s mechanism of action.<CoreSc1 atype="GSC" type="Con" conceptID="Con11" novelty="None" advantage="None"/></s>
          <s sid="193">Furthermore, we believe that these effects are, at least in part, mediated through the increased expression of erbB3 and the p160 family of SRCs (SRC-1, SRC-2, and SRC-3/AIB1) and increased Akt activity.<CoreSc1 atype="GSC" type="Con" conceptID="Con12" novelty="None" advantage="None"/></s>
          <s sid="194">Interestingly, the published observations of early exposure to BPA overlap well with the reported phenotypes of transgenic mouse models of SRC overexpression and counter models of SRC deficiency.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac60" novelty="None" advantage="None"/></s>
          <s sid="195">However, not only do the alterations reported here provide an explanation of enhanced mammary carcinogenesis after lactational treatment with BPA, but they also warn of the potential for developing more aggressive and refractory forms of breast cancer.<CoreSc1 atype="GSC" type="Con" conceptID="Con13" novelty="None" advantage="None"/></s>
          <s sid="196">In coculturing nonmalignant, random periareolar fine-needle aspirates from the contra-lateral breast of women with breast cancer, <xref ref-type="bibr" rid="b9-ehp-117-910">Dairkee et al. (2008)</xref> found that physiologic doses of estrogen and progesterone coupled to BPA produced a gene signature profile that was associated with breast tumors with high pathologic grade, greater tumor size, and shorter disease-free patient survival.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac61" novelty="None" advantage="None"/></s>
          <s sid="197">Increased expression of erbB2, erbB3, the SRCs, and Akt activation and have been linked with tamoxifen resistance (<xref ref-type="bibr" rid="b2-ehp-117-910">Bouras et al. 2001</xref>; <xref ref-type="bibr" rid="b21-ehp-117-910">Kirkegaard et al. 2007</xref>; <xref ref-type="bibr" rid="b29-ehp-117-910">Mc Ilroy et al. 2006</xref>; <xref ref-type="bibr" rid="b34-ehp-117-910">Osborne et al. 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac62" novelty="None" advantage="None"/></s>
          <s sid="198">In breast cancer patients, high SRC-3/AIB1 expression is associated with HER2 overexpression, tamoxifen resistance, and higher mortality.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac63" novelty="None" advantage="None"/></s>
          <s sid="199">If these effects found in rodents carry over to humans, even small, seemingly harmless exposures of BPA early in life could be detrimental and play a role in increased breast cancer susceptibility as well as the ability of a tumor to become resistant to therapy.<CoreSc1 atype="GSC" type="Con" conceptID="Con14" novelty="None" advantage="None"/></s>
        </p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn>
          <p>Supplemental Material is available online at <ext-link ext-link-type="uri" xlink:href="http://www.ehponline.org/members/2009/11751/suppl.pdf" xlink:type="simple">http://www.ehponline.org/members/2009/11751/suppl.pdf</ext-link></p>
        </fn>
        <fn>
          <p>We thank J. Ritchie for tumor palpations and necropsies.</p>
        </fn>
        <fn>
          <p>This research was supported by grant 1U01 ES012771 from the National Institutes of Health (NIH)/National Institute of Environmental Health Sciences. S.J. is supported through a predoctoral fellowship from the NIH/National Cancer Institute Cancer Prevention and Control Training Program, University of Alabama at Birmingham (R25 CA47888).</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="b1-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Aupperlee</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>KT</given-names>
              </name>
              <name name-style="western">
                <surname>Kariagina</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Haslam</surname>
                <given-names>SZ</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development</article-title>
            <source>Endocrinology</source>
            <volume>146</volume>
            <issue>8</issue>
            <fpage>3577</fpage>
            <lpage>3588</lpage>
          </citation>
        </ref>
        <ref id="b2-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bouras</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Southey</surname>
                <given-names>MC</given-names>
              </name>
              <name name-style="western">
                <surname>Venter</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu</article-title>
            <source>Cancer Res</source>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>903</fpage>
            <lpage>907</lpage>
          </citation>
        </ref>
        <ref id="b3-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Brede</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Fjeldal</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Skjevrak</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Herikstad</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Increased migration levels of bisphenol A from polycarbonate baby bottles after dishwashing, boiling and brushing</article-title>
            <source>Food Addit Contam</source>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>684</fpage>
            <lpage>689</lpage>
          </citation>
        </ref>
        <ref id="b4-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Brown</surname>
                <given-names>NM</given-names>
              </name>
              <name name-style="western">
                <surname>Manzolillo</surname>
                <given-names>PA</given-names>
              </name>
              <name name-style="western">
                <surname>Zhang</surname>
                <given-names>J-X</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Lamartiniere</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Prenatal TCDD and predisposition for mammary cancer</article-title>
            <source>Carcinogenesis</source>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>1623</fpage>
            <lpage>1629</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Calafat</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Kuklenyik</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Reidy</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Caudill</surname>
                <given-names>SP</given-names>
              </name>
              <name name-style="western">
                <surname>Ekong</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Needham</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population</article-title>
            <source>Environ Health Perspect</source>
            <volume>113</volume>
            <fpage>391</fpage>
            <lpage>395</lpage>
          </citation>
        </ref>
        <ref id="b6-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Calafat</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Ye</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Wong</surname>
                <given-names>LY</given-names>
              </name>
              <name name-style="western">
                <surname>Reidy</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Needham</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <year>2008</year>
            <article-title>Exposure of the U.S. population to bisphenol A and 4-<italic>tertiary</italic>-octylphenol: 2003&#8211;2004</article-title>
            <source>Environ Health Perspect</source>
            <volume>116</volume>
            <fpage>39</fpage>
            <lpage>44</lpage>
          </citation>
        </ref>
        <ref id="b7-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Colditz</surname>
                <given-names>GA</given-names>
              </name>
              <name name-style="western">
                <surname>Frazier</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <year>1995</year>
            <article-title>Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>567</fpage>
            <lpage>571</lpage>
          </citation>
        </ref>
        <ref id="b8-ehp-117-910">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Collette</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <source>Modelling Survival Data in Medical Research</source>
            <edition>2</edition>
            <publisher-loc>Boca Raton, FL</publisher-loc>
            <publisher-name>Chapman &amp; Hall/CRC</publisher-name>
          </citation>
        </ref>
        <ref id="b9-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dairkee</surname>
                <given-names>SH</given-names>
              </name>
              <name name-style="western">
                <surname>Seok</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Champion</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Sayeed</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Mindrinos</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Xiao</surname>
                <given-names>W</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2008</year>
            <article-title>Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients</article-title>
            <source>Cancer Res</source>
            <volume>68</volume>
            <issue>7</issue>
            <fpage>2076</fpage>
            <lpage>2080</lpage>
          </citation>
        </ref>
        <ref id="b10-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Durando</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Kass</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Piva</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Sonnenschein</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Soto</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Luque</surname>
                <given-names>EH</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats</article-title>
            <source>Environ Health Perspect</source>
            <volume>115</volume>
            <fpage>80</fpage>
            <lpage>86</lpage>
          </citation>
        </ref>
        <ref id="b11-ehp-117-910">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">European Commission</collab>
            <year>2003</year>
            <source>4,4&#8242;-Isopropylidenediphenol (Bisphenol-A), CAS No: 80-05-7 Summary Risk Assessment Report </source>
            <comment>Available<ext-link ext-link-type="uri" xlink:href="http://ecb.jrc.it/Documents/Existing-Chemicals/RISK_ASSESSMENT/SUMMARY/bisphenolasum325.pdf" xlink:type="simple">http://ecb.jrc.it/Documents/Existing-Chemicals/RISK_ASSESSMENT/SUMMARY/bisphenolasum325.pdf</ext-link></comment>
            <access-date>[accessed 29 April 2009].</access-date>
          </citation>
        </ref>
        <ref id="b12-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <collab xlink:type="simple">European Food Safety Authority. </collab>
            <year>2006</year>
            <article-title>Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food</article-title>
            <source>Eur Food Saf Auth J</source>
            <volume>428</volume>
            <fpage>1</fpage>
            <lpage>75</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>FJ</given-names>
              </name>
              <name name-style="western">
                <surname>Myers</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Kelly</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Crotty</surname>
                <given-names>TB</given-names>
              </name>
              <name name-style="western">
                <surname>McDermott</surname>
                <given-names>EW</given-names>
              </name>
              <name name-style="western">
                <surname>O&#8217;Higgins</surname>
                <given-names>NJ</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004</year>
            <article-title>Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1</article-title>
            <source>J Clin Pathol</source>
            <volume>57</volume>
            <issue>10</issue>
            <fpage>1069</fpage>
            <lpage>1074</lpage>
          </citation>
        </ref>
        <ref id="b14-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Herbst</surname>
                <given-names>AL</given-names>
              </name>
              <name name-style="western">
                <surname>Ulfelder</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Poskanzer</surname>
                <given-names>DC</given-names>
              </name>
              <name name-style="western">
                <surname>Longo</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971</article-title>
            <source>Am J Obstet Gynecol</source>
            <volume>181</volume>
            <issue>6</issue>
            <fpage>1574</fpage>
            <lpage>1575</lpage>
          </citation>
        </ref>
        <ref id="b15-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ho</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Tang</surname>
                <given-names>WY</given-names>
              </name>
              <name name-style="western">
                <surname>Belmonte de Frausto</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Prins</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4</article-title>
            <source>Cancer Res</source>
            <volume>66</volume>
            <issue>11</issue>
            <fpage>5624</fpage>
            <lpage>5632</lpage>
          </citation>
        </ref>
        <ref id="b16-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Howdeshell</surname>
                <given-names>KL</given-names>
              </name>
              <name name-style="western">
                <surname>Hotchkiss</surname>
                <given-names>AK</given-names>
              </name>
              <name name-style="western">
                <surname>Thayer</surname>
                <given-names>KA</given-names>
              </name>
              <name name-style="western">
                <surname>Vandenbergh</surname>
                <given-names>JG</given-names>
              </name>
              <name name-style="western">
                <surname>vom Saal</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Exposure to bisphenol A advances puberty</article-title>
            <source>Nature</source>
            <volume>401</volume>
            <issue>6755</issue>
            <fpage>763</fpage>
            <lpage>764</lpage>
          </citation>
        </ref>
        <ref id="b17-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kang</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Kito</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Kondo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Factors influencing the migration of bisphenol A from cans</article-title>
            <source>J Food Prot</source>
            <volume>66</volume>
            <issue>8</issue>
            <fpage>1444</fpage>
            <lpage>1447</lpage>
          </citation>
        </ref>
        <ref id="b18-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kang</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Kondo</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Katayama</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Human exposure to bisphenol A</article-title>
            <source>Toxicology</source>
            <volume>226</volume>
            <issue>2&#8211;3</issue>
            <fpage>79</fpage>
            <lpage>89</lpage>
          </citation>
        </ref>
        <ref id="b19-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Karamouzis</surname>
                <given-names>MV</given-names>
              </name>
              <name name-style="western">
                <surname>Badra</surname>
                <given-names>FA</given-names>
              </name>
              <name name-style="western">
                <surname>Papavassiliou</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Breast cancer: the upgraded role of HER-3 and HER-4</article-title>
            <source>Int J Biochem Cell Biol</source>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>851</fpage>
            <lpage>856</lpage>
          </citation>
        </ref>
        <ref id="b20-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kariagina</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Aupperlee</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Haslam</surname>
                <given-names>SZ</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Progesterone receptor isoforms and proliferation in the rat mammary gland during development</article-title>
            <source>Endocrinology</source>
            <volume>148</volume>
            <issue>6</issue>
            <fpage>2723</fpage>
            <lpage>2736</lpage>
          </citation>
        </ref>
        <ref id="b21-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kirkegaard</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>McGlynn</surname>
                <given-names>LM</given-names>
              </name>
              <name name-style="western">
                <surname>Campbell</surname>
                <given-names>FM</given-names>
              </name>
              <name name-style="western">
                <surname>Muller</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Tovey</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Dunne</surname>
                <given-names>B</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Amplified in breast cancer 1 in human epidermal growth factor receptor-positive tumors of tamoxifen-treated breast cancer patients</article-title>
            <source>Clin Cancer Res</source>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>1405</fpage>
            <lpage>1411</lpage>
          </citation>
        </ref>
        <ref id="b22-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kuang</surname>
                <given-names>SQ</given-names>
              </name>
              <name name-style="western">
                <surname>Liao</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Medina</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>O&#8217;Malley</surname>
                <given-names>BW</given-names>
              </name>
              <name name-style="western">
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis</article-title>
            <source>Cancer Res</source>
            <volume>65</volume>
            <issue>17</issue>
            <fpage>7993</fpage>
            <lpage>8002</lpage>
          </citation>
        </ref>
        <ref id="b23-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lahusen</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Fereshteh</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Oh</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Wellstein</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Riegel</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1</article-title>
            <source>Cancer Res</source>
            <volume>67</volume>
            <issue>15</issue>
            <fpage>7256</fpage>
            <lpage>7265</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Le</surname>
                <given-names>HH</given-names>
              </name>
              <name name-style="western">
                <surname>Carlson</surname>
                <given-names>EM</given-names>
              </name>
              <name name-style="western">
                <surname>Chua</surname>
                <given-names>JP</given-names>
              </name>
              <name name-style="western">
                <surname>Belcher</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <year>2008</year>
            <article-title>Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons</article-title>
            <source>Toxicol Lett</source>
            <volume>176</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <lpage>156</lpage>
          </citation>
        </ref>
        <ref id="b25-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Ordonez-Ercan</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Fan</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Edgerton</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Thor</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells</article-title>
            <source>Int J Cancer</source>
            <volume>120</volume>
            <issue>9</issue>
            <fpage>1874</fpage>
            <lpage>1882</lpage>
          </citation>
        </ref>
        <ref id="b26-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Markey</surname>
                <given-names>CM</given-names>
              </name>
              <name name-style="western">
                <surname>Luque</surname>
                <given-names>EH</given-names>
              </name>
              <name name-style="western">
                <surname>Munoz de Toro</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Sonnenschein</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Soto</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland</article-title>
            <source>Biol Reprod</source>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>1215</fpage>
            <lpage>1223</lpage>
          </citation>
        </ref>
        <ref id="b27-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Markey</surname>
                <given-names>CM</given-names>
              </name>
              <name name-style="western">
                <surname>Wadia</surname>
                <given-names>PR</given-names>
              </name>
              <name name-style="western">
                <surname>Rubin</surname>
                <given-names>BS</given-names>
              </name>
              <name name-style="western">
                <surname>Sonnenschein</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Soto</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract</article-title>
            <source>Biol Reprod</source>
            <volume>72</volume>
            <issue>6</issue>
            <fpage>1344</fpage>
            <lpage>1351</lpage>
          </citation>
        </ref>
        <ref id="b28-ehp-117-910">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>McCullagh</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Nelder</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <source>Generalized Linear Models</source>
            <edition>2</edition>
            <publisher-loc>London</publisher-loc>
            <publisher-name>Chapman &amp; Hall</publisher-name>
          </citation>
        </ref>
        <ref id="b29-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mc Ilroy</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>FJ</given-names>
              </name>
              <name name-style="western">
                <surname>Buggy</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Hill</surname>
                <given-names>AD</given-names>
              </name>
              <name name-style="western">
                <surname>Young</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence</article-title>
            <source>Endocr Relat Cancer</source>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>1135</fpage>
            <lpage>1145</lpage>
          </citation>
        </ref>
        <ref id="b30-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Meyer</surname>
                <given-names>JS</given-names>
              </name>
              <name name-style="western">
                <surname>Alvarez</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Milikowski</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Olson</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index</article-title>
            <source>Mod Pathol</source>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>1067</fpage>
            <lpage>1078</lpage>
          </citation>
        </ref>
        <ref id="b31-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Munoz-de-Toro</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Markey</surname>
                <given-names>CM</given-names>
              </name>
              <name name-style="western">
                <surname>Wadia</surname>
                <given-names>PR</given-names>
              </name>
              <name name-style="western">
                <surname>Luque</surname>
                <given-names>EH</given-names>
              </name>
              <name name-style="western">
                <surname>Rubin</surname>
                <given-names>BS</given-names>
              </name>
              <name name-style="western">
                <surname>Sonnenschein</surname>
                <given-names>C</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Perinatal exposure to bis-phenol-A alters peripubertal mammary gland development in mice</article-title>
            <source>Endocrinology</source>
            <volume>146</volume>
            <issue>9</issue>
            <fpage>4138</fpage>
            <lpage>4147</lpage>
          </citation>
        </ref>
        <ref id="b32-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Murray</surname>
                <given-names>TJ</given-names>
              </name>
              <name name-style="western">
                <surname>Maffini</surname>
                <given-names>MV</given-names>
              </name>
              <name name-style="western">
                <surname>Ucci</surname>
                <given-names>AA</given-names>
              </name>
              <name name-style="western">
                <surname>Sonnenschein</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Soto</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure</article-title>
            <source>Reprod Toxicol</source>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>383</fpage>
            <lpage>390</lpage>
          </citation>
        </ref>
        <ref id="b33-ehp-117-910">
          <citation citation-type="web" xlink:type="simple">
            <collab xlink:type="simple">National Toxicology Program</collab>
            <year>1982</year>
            <source>Carcinogenesis Bioassay of Bisphenol A (CAS No 80-05-7) in F344 Rats and B6C3F1 Mice (Feed Study) TR 215 </source>
            <publisher-name>Research Triangle Park</publisher-name>
            <source>NC:National Toxicology Program </source>
            <comment>Available<ext-link ext-link-type="uri" xlink:href="http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr215.pdf" xlink:type="simple">http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr215.pdf</ext-link></comment>
            <access-date>[accessed 24 April 2009].</access-date>
          </citation>
        </ref>
        <ref id="b34-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Osborne</surname>
                <given-names>CK</given-names>
              </name>
              <name name-style="western">
                <surname>Bardou</surname>
                <given-names>V</given-names>
              </name>
              <name name-style="western">
                <surname>Hopp</surname>
                <given-names>TA</given-names>
              </name>
              <name name-style="western">
                <surname>Chamness</surname>
                <given-names>GC</given-names>
              </name>
              <name name-style="western">
                <surname>Hilsenbeck</surname>
                <given-names>SG</given-names>
              </name>
              <name name-style="western">
                <surname>Fuqua</surname>
                <given-names>SA</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003</year>
            <article-title>Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>353</fpage>
            <lpage>361</lpage>
          </citation>
        </ref>
        <ref id="b35-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rubin</surname>
                <given-names>BS</given-names>
              </name>
              <name name-style="western">
                <surname>Murray</surname>
                <given-names>MK</given-names>
              </name>
              <name name-style="western">
                <surname>Damassa</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>King</surname>
                <given-names>JC</given-names>
              </name>
              <name name-style="western">
                <surname>Soto</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels</article-title>
            <source>Envrion Health Perspect</source>
            <volume>109</volume>
            <fpage>675</fpage>
            <lpage>680</lpage>
          </citation>
        </ref>
        <ref id="b36-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>IH</given-names>
              </name>
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <year>1978</year>
            <article-title>Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[<italic>a</italic>]anthracene</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>1439</fpage>
            <lpage>1449</lpage>
          </citation>
        </ref>
        <ref id="b37-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Gusterson</surname>
                <given-names>BA</given-names>
              </name>
              <name name-style="western">
                <surname>Rogers</surname>
                <given-names>AE</given-names>
              </name>
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>IH</given-names>
              </name>
              <name name-style="western">
                <surname>Wellings</surname>
                <given-names>SR</given-names>
              </name>
              <name name-style="western">
                <surname>van Zwieten</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Comparative study of human and rat mammary tumorigenesis</article-title>
            <source>Lab Invest</source>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>244</fpage>
            <lpage>278</lpage>
          </citation>
        </ref>
        <ref id="b38-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Russo</surname>
                <given-names>IH</given-names>
              </name>
            </person-group>
            <year>1978</year>
            <article-title>DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>1451</fpage>
            <lpage>1459</lpage>
          </citation>
        </ref>
        <ref id="b39-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schiff</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Massarweh</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Shou</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Osborne</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response</article-title>
            <source>Clin Cancer Res</source>
            <volume>9</volume>
            <issue>1 pt 2</issue>
            <fpage>447S</fpage>
            <lpage>454S</lpage>
          </citation>
        </ref>
        <ref id="b40-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shyamala</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Silberstein</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Barcellos-Hoff</surname>
                <given-names>MH</given-names>
              </name>
              <name name-style="western">
                <surname>Dale</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands</article-title>
            <source>Proc Natl Acad Sci USA</source>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>696</fpage>
            <lpage>701</lpage>
          </citation>
        </ref>
        <ref id="b41-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Irie</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Kishikawa</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Wada</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Kuroda</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Nakashima</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>Determination of bisphenol A in human breast milk by HPLC with column-switching and fluorescence detection</article-title>
            <source>Biomed Chromatogr</source>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>501</fpage>
            <lpage>507</lpage>
          </citation>
        </ref>
        <ref id="b42-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Torres-Arzayus</surname>
                <given-names>MI</given-names>
              </name>
              <name name-style="western">
                <surname>Font de Mora</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Yuan</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Vazquez</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Bronson</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Rue</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004</year>
            <article-title>High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene</article-title>
            <source>Cancer Cell</source>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <lpage>274</lpage>
          </citation>
        </ref>
        <ref id="b43-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Troisi</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Hatch</surname>
                <given-names>EE</given-names>
              </name>
              <name name-style="western">
                <surname>Titus-Ernstoff</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Hyer</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Palmer</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Robboy</surname>
                <given-names>SJ</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Cancer risk in women prenatally exposed to diethylstilbestrol</article-title>
            <source>Int J Cancer</source>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>356</fpage>
            <lpage>360</lpage>
          </citation>
        </ref>
        <ref id="b44-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wadia</surname>
                <given-names>PR</given-names>
              </name>
              <name name-style="western">
                <surname>Vandenberg</surname>
                <given-names>LN</given-names>
              </name>
              <name name-style="western">
                <surname>Schaeberle</surname>
                <given-names>CM</given-names>
              </name>
              <name name-style="western">
                <surname>Rubin</surname>
                <given-names>BS</given-names>
              </name>
              <name name-style="western">
                <surname>Sonnenschein</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Soto</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains</article-title>
            <source>Environ Health Perspect</source>
            <volume>115</volume>
            <fpage>592</fpage>
            <lpage>598</lpage>
          </citation>
        </ref>
        <ref id="b45-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wilson</surname>
                <given-names>NK</given-names>
              </name>
              <name name-style="western">
                <surname>Chuang</surname>
                <given-names>JC</given-names>
              </name>
              <name name-style="western">
                <surname>Morgan</surname>
                <given-names>MK</given-names>
              </name>
              <name name-style="western">
                <surname>Lordo</surname>
                <given-names>RA</given-names>
              </name>
              <name name-style="western">
                <surname>Sheldon</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare</article-title>
            <source>Environ Res</source>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <lpage>20</lpage>
          </citation>
        </ref>
        <ref id="b46-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wolff</surname>
                <given-names>MS</given-names>
              </name>
              <name name-style="western">
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Windham</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Pinney</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Britton</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Chelimo</surname>
                <given-names>C</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls</article-title>
            <source>Environ Health Perspect</source>
            <volume>115</volume>
            <fpage>116</fpage>
            <lpage>121</lpage>
          </citation>
        </ref>
        <ref id="b47-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Liao</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Ning</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Yoshida-Komiya</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Deng</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>O&#8217;Malley</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development</article-title>
            <source>Proc Natl Acad Sci USA</source>
            <volume>97</volume>
            <issue>12</issue>
            <fpage>6379</fpage>
            <lpage>6384</lpage>
          </citation>
        </ref>
        <ref id="b48-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Qiu</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>DeMayo</surname>
                <given-names>FJ</given-names>
              </name>
              <name name-style="western">
                <surname>Tsai</surname>
                <given-names>SY</given-names>
              </name>
              <name name-style="western">
                <surname>Tsai</surname>
                <given-names>MJ</given-names>
              </name>
              <name name-style="western">
                <surname>O&#8217;Malley</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene</article-title>
            <source>Science</source>
            <volume>279</volume>
            <issue>5358</issue>
            <fpage>1922</fpage>
            <lpage>1925</lpage>
          </citation>
        </ref>
        <ref id="b49-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Xu</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Sadamatsu</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Tsutsumi</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Akaike</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Ushijima</surname>
                <given-names>H</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Perinatal bisphenol A affects the behavior and SRC-1 expression of male pups but does not influence on the thyroid hormone receptors and its responsive gene</article-title>
            <source>Neurosci Res</source>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <lpage>155</lpage>
          </citation>
        </ref>
        <ref id="b50-ehp-117-910">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ye</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Kuklenyik</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Needham</surname>
                <given-names>LL</given-names>
              </name>
              <name name-style="western">
                <surname>Calafat</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry</article-title>
            <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>
            <volume>831</volume>
            <issue>1&#8211;2</issue>
            <fpage>110</fpage>
            <lpage>115</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>